QTREX Quantum Ltd. (QTEX)

Data as of Oct 15, 2026, from SEC Form 4 filings.

NasdaqNet insider buying (90d)Watch QTEX

See up to 3 months of QTEX. The 7-day demo opens the 1M and 3M ranges and puts QTEX on your watchlist.

Latest QTEX insider trades

Tal Parnes - Director
Open-market purchase$10K
Oct 15, 2026
Dagi Shahar Ben-Noon - Officer

About QTREX Quantum Ltd. (QTEX)

QTREX Quantum Ltd designs and manufactures cryogenic interconnect systems used in quantum computing systems. Its activities focus on technologies related to manufacturing, materials science, and quantum engineering.

Employees: 41
Listed: 2021
Exchange: Nasdaq
Sector: Health Care

https://q-trex.com SEC filings for QTEX on EDGAR

QTEX Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market purchase	3	38,940	$61K
Grant or award	5	1,920,000

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

QTEX insider transactions (Form 4)

16 Form 4 filings on record, the earliest from May 29, 2026, newest first.

Traded	Insider	Transaction	Security	Shares	Price	Value
Oct 15, 2026	Tal Parnes - Director	Open-market purchase	Ordinary Shares	6,666^{footnote F1}	$1.50	$10K
Footnote F1 (shares): The shares were purchased in the open market.
Oct 13, 2026	Dagi Shahar Ben-Noon - Officer	Open-market purchase	Ordinary Shares	14,093^{footnote F1}	$1.49	$21K
Footnote F1 (shares): The shares were purchased in the open market. The purchase was made as part of the management share purchase plan announced by the Company on June 22, 2026.
Oct 9, 2026	Dagi Shahar Ben-Noon - Officer	Open-market purchase	Ordinary Shares	18,181^{footnote F1}	$1.67	$30K
Footnote F1 (shares): The shares were purchased in the open market. The purchase was made as part of the management share purchase plan announced by the Company on June 22, 2026.
Aug 28, 2026	Dagi Shahar Ben-Noon - Officer	Grant or award	Ordinary Shares	550,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR
Aug 28, 2026	Tal Parnes - Director	Grant or award	Ordinary Shares	550,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR
Aug 28, 2026	Sivan Matza - Director	Grant or award	Ordinary Shares	100,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR
Aug 28, 2026	Lior Amit - Director	Grant or award	Ordinary Shares	170,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR
Aug 28, 2026	Dagi Shahar Ben-Noon - Officer	Grant or award	Ordinary Shares	550,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR
Jul 6, 2026	Abraham Shabtay - Officer	Grant or award	Ordinary Shares	550,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR
Jul 6, 2026	Yoav Rozanovich - Officer	Grant or award	Ordinary Shares	550,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on October 1, 2026, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR
Jul 6, 2026	Hayon Daniella Yechezkely - Officer	Grant or award	Ordinary Shares	550,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR
Jul 6, 2026	Yafit Tehila - Officer	Grant or award	Ordinary Shares	550,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR
May 29, 2026	Hayon Daniella Yechezkely - Officer	Open-market sale	Ordinary Shares	50,000^{footnote F1}	$3.00	$150K
Footnote F1 (shares): Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying… Full note on SEC EDGAR
May 29, 2026	Yafit Tehila - Officer	Open-market sale	Ordinary Shares	1,900^{footnote F1}	$3.51	$7K
Jun 1, 2026	Yafit Tehila - Officer	Open-market sale	Ordinary Shares	28,100^{footnote F1}	$3.50	$98K
Footnote F1 (shares): Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying… Full note on SEC EDGAR
May 29, 2026	Abraham Shabtay - Officer	Option exercise	Ordinary Shares	95,239	$3.37	$321K
May 29, 2026	Abraham Shabtay - Officer	Option exercise	Employee share options (right to buy)	57,144^{footnote F2}	$0.00	-
May 29, 2026	Abraham Shabtay - Officer	Option exercise	Employee share options (right to buy)	38,095^{footnote F4}	$0.00	-
Footnote F2 (shares): The options were granted with an exercise price of AUD 0.37. Footnote F4 (shares): The options were granted with an exercise price of NIS 0.37.
May 27, 2026	Yafit Tehila - Officer	Option exercise	Ordinary Shares	13,605^{footnote F2}	$0.12	$2K
May 27, 2026	Yafit Tehila - Officer	Open-market sale	Ordinary Shares	13,605^{footnote F2}	$2.03	$28K
May 27, 2026	Yafit Tehila - Officer	Open-market sale	Ordinary Shares	16,395^{footnote F2}	$2.01	$33K
May 28, 2026	Yafit Tehila - Officer	Open-market sale	Ordinary Shares	15,000^{footnote F2}	$2.56	$38K
May 28, 2026	Yafit Tehila - Officer	Open-market sale	Ordinary Shares	15,000^{footnote F2}	$3.00	$45K
May 28, 2026	Yafit Tehila - Officer	Option exercise	Employee share options (right to buy)	13,605^{footnote F2}	$0.00	-
Footnote F2 (shares): The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan.

Recent QTEX Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Jun 1, 2026	-	-	-	-	View on EDGAR
Jun 1, 2026	-	-	-	-

QTEX insider trading FAQ

What is the latest insider trade for QTEX?

QTREX Quantum Ltd. (QTEX) had 8 insider filings in the last 90 days, with the most recent on 15 October 2026. The full record for QTEX runs to 16 Form 4 filings, the earliest from 29 May 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying QTEX stock?

3 insider purchases of QTEX were filed in the last 90 days, totaling $61K.

How many insiders are selling QTEX stock?

No insider sales of QTEX were filed in the last 90 days. 7 sales are on record for this company.

Where can I see QTEX SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects QTEX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 15, 2026 - Tal Parnes view on EDGAR
Oct 13, 2026 - Dagi Shahar Ben-Noon view on EDGAR
Oct 9, 2026 - Dagi Shahar Ben-Noon view on EDGAR
Sep 29, 2026 - Dagi Shahar Ben-Noon view on EDGAR
Sep 1, 2026 - Tal Parnes view on EDGAR
Sep 1, 2026 - Sivan Matza view on EDGAR
Sep 1, 2026 - Lior Amit view on EDGAR
Sep 1, 2026 - Dagi Shahar Ben-Noon view on EDGAR
Jul 15, 2026 - Abraham Shabtay view on EDGAR

Related companies with recent insider activity

Learn more

How to read insider buying signals: What an open-market purchase by an insider can and cannot tell you.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where QTEX's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow QTEX with a 7-day demo

QTEX on your watchlist
Every QTEX Form 4 filing on record
Up to 3 months of QTEX price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market purchase

38,940

$61K

Grant or award

1,920,000

Traded

Insider

Transaction

Security

Price

Value

Oct 15, 2026

Tal Parnes - Director

Open-market purchase

Ordinary Shares

6,666^{footnote F1}

$1.50

$10K

Footnote F1 (shares): The shares were purchased in the open market.

Oct 13, 2026

Dagi Shahar Ben-Noon - Officer

Open-market purchase

Ordinary Shares

14,093^{footnote F1}

$1.49

$21K

Footnote F1 (shares): The shares were purchased in the open market. The purchase was made as part of the management share purchase plan announced by the Company on June 22, 2026.

Oct 9, 2026

Dagi Shahar Ben-Noon - Officer

Open-market purchase

Ordinary Shares

18,181^{footnote F1}

$1.67

$30K

Footnote F1 (shares): The shares were purchased in the open market. The purchase was made as part of the management share purchase plan announced by the Company on June 22, 2026.

Aug 28, 2026

Dagi Shahar Ben-Noon - Officer

Grant or award

Ordinary Shares

550,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR

Aug 28, 2026

Tal Parnes - Director

Grant or award

Ordinary Shares

550,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR

Aug 28, 2026

Sivan Matza - Director

Grant or award

Ordinary Shares

100,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR

Aug 28, 2026

Lior Amit - Director

Grant or award

Ordinary Shares

170,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR

Aug 28, 2026

Dagi Shahar Ben-Noon - Officer

Grant or award

Ordinary Shares

550,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment")… Full note on SEC EDGAR

Jul 6, 2026

Abraham Shabtay - Officer

Grant or award

Ordinary Shares

550,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR

Jul 6, 2026

Yoav Rozanovich - Officer

Grant or award

Ordinary Shares

550,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on October 1, 2026, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR

Jul 6, 2026

Hayon Daniella Yechezkely - Officer

Grant or award

Ordinary Shares

550,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR

Jul 6, 2026

Yafit Tehila - Officer

Grant or award

Ordinary Shares

550,000^{footnote F1}

$0.00

Footnote F1 (shares): The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years… Full note on SEC EDGAR

May 29, 2026

Hayon Daniella Yechezkely - Officer

Open-market sale

Ordinary Shares

50,000^{footnote F1}

$3.00

$150K

Footnote F1 (shares): Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying… Full note on SEC EDGAR

May 29, 2026

Yafit Tehila - Officer

Open-market sale

Ordinary Shares

1,900^{footnote F1}

$3.51

$7K

Jun 1, 2026

Yafit Tehila - Officer

Open-market sale

Ordinary Shares

28,100^{footnote F1}

$3.50

$98K

Footnote F1 (shares): Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying… Full note on SEC EDGAR

May 29, 2026

Abraham Shabtay - Officer

Option exercise

Ordinary Shares

95,239

$3.37

$321K

May 29, 2026

Abraham Shabtay - Officer

Option exercise

Employee share options (right to buy)

57,144^{footnote F2}

$0.00

May 29, 2026

Abraham Shabtay - Officer

Option exercise

Employee share options (right to buy)

38,095^{footnote F4}

$0.00

Footnote F2 (shares): The options were granted with an exercise price of AUD 0.37.
Footnote F4 (shares): The options were granted with an exercise price of NIS 0.37.

May 27, 2026

Yafit Tehila - Officer

Option exercise

Ordinary Shares

13,605^{footnote F2}

$0.12

$2K

May 27, 2026

Yafit Tehila - Officer

Open-market sale

Ordinary Shares

13,605^{footnote F2}

$2.03

$28K

May 27, 2026

Yafit Tehila - Officer

Open-market sale

Ordinary Shares

16,395^{footnote F2}

$2.01

$33K

May 28, 2026

Yafit Tehila - Officer

Open-market sale

Ordinary Shares

15,000^{footnote F2}

$2.56

$38K

May 28, 2026

Yafit Tehila - Officer

Open-market sale

Ordinary Shares

15,000^{footnote F2}

$3.00

$45K

May 28, 2026

Yafit Tehila - Officer

Option exercise

Employee share options (right to buy)

13,605^{footnote F2}

$0.00

Footnote F2 (shares): The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan.

Filed

Filer

Relationship

Market value

Notice

Jun 1, 2026

View on EDGAR

Jun 1, 2026